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Previous studies suggested that alterations in serum cortisol levels
may play a role in the pathophysiology of schizophrenia. Imbalance in
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Serum levels of cortisol and DHEA-S in the examined and control group
Hormone Examined group Control group test p-value
Cortisol 555.7 ± 159.8 351.7 ± 172.1 t = 6.07 0.00000 
DHEA-S 329.5 ± 125.1 167.4 ± 57.5 t = 7.66 0.00000 
To compare serum cortisol levels between patients with
schizophrenia and healthy controls and to evaluate hormone
association with psychopathology and response to antipsychotics in
patients with schizophrenia.
Serum cortisol and DHEA-S levels were determinated with
chemiluminescent enzyme immunoassay (CLIA) methods of
Immulite 2000 analyzers,
Elevated serum cortisol levels may be considered as a biomarker
for the diagnosis of schizophrenia and may be used as a
significant predictor for positive response to antipsychotic
treatment in schizophrenia patients with acute exacerbation.
Serum cortisol levels are associated with severity of specific
symptoms in patients with schizophrenia according to their
responsitivity to antipsychotic treatment.
This clinical prospective study included 60 patients with
schizophrenia and 40 healthy age and sex matched controls. All
patients experienced an acute exacerbation of the illness (PANSS:
P1 and P3 ≥ 4). Clinical evaluation of patients was performed using
the Positive and Negative Symptom Scale. A questionnaire for
socio-demographic and clinical data collection was used. For the
purposes of the study, the examined group was divided in two
subgroups: responders and nonresponders. Serum cortisol and
DHEA-S levels were measured at baseline in all participants and
after 3 and 6 weeks of the antipsychotic treatment in patients with
schizophrenia.
Material
Patients with schizophrenia had significantly higher
serum cortisol levels compared with control group.
Responders had significantly higher serum cortisol
levels compared with nonresponders. From the three
analyzed factors (serum cortisol, DHEA-S and
cortisol/DHEA-S ratio), only serum cortisol was
significant factor for antipsychotic treatment response.
Responders group had significant correlation between
serum cortisol and PANSS positive scale score.
.
Figure 1. Positive and negative PANSS.
